ta 993 has been researched along with Thrombosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, H; Kaburaki, M; Murata, S; Narita, H; Yasoshima, A | 1 |
| Doi, H; Kaburaki, M; Murata, S; Narita, H; Odawara, A; Yasoshima, A | 1 |
2 other study(ies) available for ta 993 and Thrombosis
| Article | Year |
|---|---|
Antithrombotic effect of TA-993, a novel 1,5-benzothiazepine derivative, in conscious rats.
Topics: Administration, Oral; Animals; Antithrombins; Aspirin; Diltiazem; Dose-Response Relationship, Drug; Embolism; Male; Microscopy, Electron; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thrombosis; Ticlopidine; Time Factors | 1995 |
Antithrombotic action of TA-993, a new 1,5-benzothiazepine derivative, in a canine model of femoral arterial thrombosis.
Topics: Animals; Antithrombins; Diltiazem; Disease Models, Animal; Dogs; Duodenum; Electric Stimulation; Female; Femoral Artery; Male; Microscopy, Electron, Scanning; Platelet Aggregation Inhibitors; Regional Blood Flow; Thrombosis | 1998 |